Ceptaris Therapeutics

September 24, 2013

Cancer Drug Developed by UAMS Professor Receives FDA Approval

Ben Boulden

Sept. 24, 2013 | Valchlor, a breakthrough gel for treating lymphoma developed with the help of University of Arkansas for Medical Sciences (UAMS) College of Pharmacy Professor Peter Crooks, Ph.D., recently won marketing approval from the U.S. Food and Drug Administration.

Cancer Drug Developed by UAMS Professor Awarded FDA Approval

Ben Boulden

LITTLE ROCK — Valchlor, a breakthrough gel for treating lymphoma developed with the help of University of Arkansas for Medical Sciences (UAMS) College of Pharmacy Professor Peter Crooks, Ph.D., recently won marketing approval from the U.S. Food and Drug Administration.